3.07
price up icon1.99%   0.06
after-market After Hours: 3.08 0.01 +0.33%
loading
Abvc Biopharma Inc stock is traded at $3.07, with a volume of 28,787. It is up +1.99% in the last 24 hours and up +56.63% over the past month. ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
See More
Previous Close:
$3.01
Open:
$3.025
24h Volume:
28,787
Relative Volume:
0.07
Market Cap:
$52.13M
Revenue:
$152.40K
Net Income/Loss:
$-10.52M
P/E Ratio:
-1.2314
EPS:
-2.4931
Net Cash Flow:
$-4.26M
1W Performance:
-12.78%
1M Performance:
+56.63%
6M Performance:
+475.45%
1Y Performance:
+287.63%
1-Day Range:
Value
$2.98
$3.075
1-Week Range:
Value
$2.95
$3.6092
52-Week Range:
Value
$0.40
$5.48

Abvc Biopharma Inc Stock (ABVC) Company Profile

Name
Name
Abvc Biopharma Inc
Name
Phone
510-668-0881
Name
Address
44370 OLD WARM SPRINGS BLVD., FREMONT
Name
Employee
19
Name
Twitter
Name
Next Earnings Date
2024-12-13
Name
Latest SEC Filings
Name
ABVC's Discussions on Twitter

Compare ABVC with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ABVC
Abvc Biopharma Inc
3.07 51.11M 152.40K -10.52M -4.26M -2.4931
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Abvc Biopharma Inc Stock (ABVC) Latest News

pulisher
Jul 23, 2025

Is ABVC BioPharma Inc. a good long term investmentConsistent double returns - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Sixteen new option listings on July 23rd - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

ABVC BioPharma Inc Inc. (ABVC) Price Performance: A Comparative Analysis with Competitors - investchronicle.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives ABVC BioPharma Inc. stock priceFree Buy/Sell Signal Notifications - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about ABVC BioPharma Inc. stockFree AI-Backed Trading Signals - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Is ABVC BioPharma Inc. stock a growth or value playAlpha Stock Ideas - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

ABVC BioPharma Inc. Stock Analysis and ForecastFree Advanced Stock Screener Access - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 18, 2025

What makes ABVC BioPharma Inc. stock attractive to long term investorsValue Pick Scanner - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

ABVC BioPharma Records $100,000 Licensing Milestone From ForSeeCon, Strengthening Eye Health Program - Yahoo Finance

Jul 18, 2025
pulisher
Jul 15, 2025

What makes ABVC BioPharma Inc. stock price move sharplySteady Profit Stock Forecasts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why ABVC BioPharma Inc. stock attracts strong analyst attentionDaily Gain Forecast - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How ABVC BioPharma Inc. stock performs during market volatilityFree Exclusive Access to Stock Gurus - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

ABVC BioPharma Soars 16%—Is This the Breakout Biotech Investors Have Been Waiting For? - AInvest

Jul 11, 2025
pulisher
Jul 10, 2025

ABVC BioPharma Receives $150K Milestone From AiBtl, Bringing Total Licensing Revenue to $846K Across Strategic Partnerships - Yahoo Finance

Jul 10, 2025
pulisher
Jun 26, 2025

ABVC BioPharma CEO Dr. Uttam Patil Recognized Among Elite Indian-Origin CEOs Making Global Impact in Science and Technology - StreetInsider

Jun 26, 2025
pulisher
Jun 24, 2025

ABVC BioPharma Converts Strategic Note Into Equity in AiBtl BioPharma; Commits to Up to $20 Million in Total Investment - Yahoo Finance

Jun 24, 2025
pulisher
Jun 07, 2025

ABVC BioPharma's Affiliate OncoX Acquires Lycopenoid Platform to Strengthen Oncology Portfolio - citybuzz -

Jun 07, 2025
pulisher
Jun 06, 2025

ABVC BioPharma Expands Oncology Portfolio as Affiliate OncoX Acquires Patented Lycopenoid Platform Valued at $4.06 Million - The Globe and Mail

Jun 06, 2025
pulisher
Jun 04, 2025

ABVC BioPharma Shareholders Approve Key Proposals - TipRanks

Jun 04, 2025
pulisher
Jun 03, 2025

ABVC BioPharma Announces Board Approval of Share Dividend Showing Confidence in Subsidiary Growth and Long-Term Shareholder Value - Yahoo Finance

Jun 03, 2025
pulisher
Jun 01, 2025

ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Up 40.0% in May - Defense World

Jun 01, 2025
pulisher
May 26, 2025

3 Top Growth Stocks to Buy in the Second Half of 2025 - The Globe and Mail

May 26, 2025
pulisher
May 22, 2025

ABVC BioPharma Files $100 Million Mixed Shelf - marketscreener.com

May 22, 2025

Abvc Biopharma Inc Stock (ABVC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Cap:     |  Volume (24h):